Pneumonia and Empyema in Emergency Departments in Children

NCT05274607 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-02-08

No results posted yet for this study

Summary

Describe the epidemiology of hospitalized pediatric pneumonia and pneumonia with pleural effusion: frequency, clinical and biological characteristics, responsible bacteria and pneumococcus place, antibiotic resistance, treatment, vaccine status.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY
  • Association Clinique Thérapeutique Infantile du val de Marne

    lead OTHER

Principal Investigators

  • Robert Cohen, MD · Groupe de Pathologies Infectieuses Pédiatriques (GPIP)

Eligibility

Min Age
1 Month
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-01
Primary Completion
2025-06-01
Completion
2025-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274607 on ClinicalTrials.gov